Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Julien Mazières, Alexander Edward Dela Cruz Drilon, Amélie Lusque, Laurent Mhanna, Alexis Benjamin Cortot, Laura Mezquita, Alesha A. Thai, Céline Mascaux, S. Couraud, Rémi Veillon, Michel M. van den Heuvel, Joel W. Neal, Nir Peled, Martin Früh, Terry L. Ng, Valérie Gounant, Sanjay Popat, Joachim Diebold, Joshua K. Sabari, Viola Weijia Zhu, Sacha I. Rothschild, Paolo Bironzo, Alex Martínez‐Martí, Alessandra Curioni Fontecedro, Rafael Rosell, and 13 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1093/annonc/mdz167
- Published
- May 15, 2019
- Venue
- Annals of Oncology
- DOI
- 10.1093/annonc/mdz167
- PubMed
- 31125062
- Categories
- Cancer Immunotherapy and Biomarkers
- Provenance
- openalex